These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Kraft AD; Kaltenbach LS; Lo DC; Harry GJ Neurobiol Aging; 2012 Mar; 33(3):621.e17-33. PubMed ID: 21482444 [TBL] [Abstract][Full Text] [Related]
5. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. Lu B; Palacino J FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320 [TBL] [Abstract][Full Text] [Related]
6. Human-to-mouse prion-like propagation of mutant huntingtin protein. Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146 [TBL] [Abstract][Full Text] [Related]
7. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. Chou SY; Weng JY; Lai HL; Liao F; Sun SH; Tu PH; Dickson DW; Chern Y J Neurosci; 2008 Mar; 28(13):3277-90. PubMed ID: 18367595 [TBL] [Abstract][Full Text] [Related]
8. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease. Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686 [TBL] [Abstract][Full Text] [Related]
9. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain. Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145 [TBL] [Abstract][Full Text] [Related]
10. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease. Lu XH; Mattis VB; Wang N; Al-Ramahi I; van den Berg N; Fratantoni SA; Waldvogel H; Greiner E; Osmand A; Elzein K; Xiao J; Dijkstra S; de Pril R; Vinters HV; Faull R; Signer E; Kwak S; Marugan JJ; Botas J; Fischer DF; Svendsen CN; Munoz-Sanjuan I; Yang XW Sci Transl Med; 2014 Dec; 6(268):268ra178. PubMed ID: 25540325 [TBL] [Abstract][Full Text] [Related]
11. Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo. Trushina E; Canaria CA; Lee DY; McMurray CT Hum Mol Genet; 2014 Jan; 23(1):129-44. PubMed ID: 24021477 [TBL] [Abstract][Full Text] [Related]
12. Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading. Yefimova MG; Béré E; Cantereau-Becq A; Meunier-Balandre AC; Merceron B; Burel A; Merienne K; Ravel C; Becq F; Bourmeyster N Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884576 [TBL] [Abstract][Full Text] [Related]
13. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice. Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618 [TBL] [Abstract][Full Text] [Related]
14. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease. Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081 [TBL] [Abstract][Full Text] [Related]
15. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes. Hong Y; Zhao T; Li XJ; Li S J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927 [TBL] [Abstract][Full Text] [Related]
16. Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function. Kim SH; Thomas CA; André VM; Cummings DM; Cepeda C; Levine MS; Ehrlich ME ASN Neuro; 2011 Jun; 3(3):e00060. PubMed ID: 21542802 [TBL] [Abstract][Full Text] [Related]
17. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease. Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181 [TBL] [Abstract][Full Text] [Related]
18. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model. Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297 [TBL] [Abstract][Full Text] [Related]
20. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]